AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 3553496 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril (with diuretic)
Number of subjects: 626
Study 3553496 — intervention group
Group type: EXPERIMENTAL
Intervention: Methyldopa (with diuretic)
Number of subjects: 626
Study 3553496 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol (with diuretic)
Number of subjects: 626
Study 3553496 — intervention group
Group type: COMPARATOR
Intervention: Methyldopa and Propranolol
Number of subjects: 626
Study 3553496 — intervention group
Group type: COMPARATOR
Intervention: All drug groups
Number of subjects: 626
Study 31050023 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal baclofen
Number of subjects: 36
Study 31050023 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 29078364 — intervention group
Group type: EXPERIMENTAL
Intervention: ND-embedded gutta percha (NDGP)
Number of subjects: 4
Study 29078364 — intervention group
Group type: COMPARATOR
Intervention: Unmodified gutta percha (GP)
Number of subjects: 4
Study 25539478 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-week neuromuscular exercise program targeting neutral lower limb alignment
Number of subjects: 62
Study 25539478 — intervention group
Group type: COMPARATOR
Intervention: Control group with no exercise
Number of subjects: 62
Study 23706037 — intervention group
Group type: EXPERIMENTAL
Intervention: Low fidelity simulation
Number of subjects: 0
Study 23706037 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium fidelity simulation
Number of subjects: 0
Study 23706037 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive fidelity simulation
Number of subjects: 0
Study 23706037 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 22142346 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple-combination therapy (Olmesartan 40 mg, Amlodipine 10 mg, Hydrochlorothiazide 25 mg)
Number of subjects: 440
Study 22142346 — intervention group
Group type: COMPARATOR
Intervention: Dual-combination (Olmesartan 40 mg + Amlodipine 10 mg)
Number of subjects: 440
Study 22142346 — intervention group
Group type: COMPARATOR
Intervention: Dual-combination (Olmesartan 40 mg + Hydrochlorothiazide 25 mg)
Number of subjects: 440
Study 22142346 — intervention group
Group type: COMPARATOR
Intervention: Dual-combination (Amlodipine 10 mg + Hydrochlorothiazide 25 mg)
Number of subjects: 440
Study 20225470 — intervention group
Group type: EXPERIMENTAL
Intervention: F dentifrice (1500 microg F/g as sodium monofluorophosphate)
Number of subjects: 10
Study 20225470 — intervention group
Group type: EXPERIMENTAL
Intervention: F dentifrice containing 0.13% CaGP
Number of subjects: 10
Study 20225470 — intervention group
Group type: COMPARATOR
Intervention: Non-F dentifrice (negative control)
Number of subjects: 10
Study 16979104 — intervention group
Group type: EXPERIMENTAL
Intervention: Water samples treated with positive intention
Number of subjects: 2000
Study 16979104 — intervention group
Group type: COMPARATOR
Intervention: Control water samples (not treated with intention)
Number of subjects: 2000
Study 15187507 — intervention group
Group type: EXPERIMENTAL
Intervention: Hospital policies for determining brain death certification
Number of subjects: 600
Study 15187507 — intervention group
Group type: COMPARATOR
Intervention: Larger hospitals
Number of subjects: 600
Study 12411789 — intervention group
Group type: COMPARATOR
Intervention: ondansetron (4 mg intravenous) with sham ReliefBand
Number of subjects: 120
Study 12411789 — intervention group
Group type: EXPERIMENTAL
Intervention: acustimulation (saline 2 ml intravenous) with active ReliefBand
Number of subjects: 120
Study 12411789 — intervention group
Group type: EXPERIMENTAL
Intervention: ondansetron (4 mg intravenous) with active ReliefBand
Number of subjects: 120
Study 9719999 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (media campaign, classroom workshops, school meal modification, parental support)
Number of subjects: 2213
Study 9719999 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group
Number of subjects: 2213
Study 9719999 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 2213
Study 7661353 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE with 40 mg intrathecal 2% lidocaine
Number of subjects: 90
Study 7661353 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE with 60 mg intrathecal 2% lidocaine
Number of subjects: 90
Study 7661353 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE with 80 mg intrathecal 2% lidocaine
Number of subjects: 90
Study 2669718 — intervention group
Group type: EXPERIMENTAL
Intervention: 10% povidone-iodine pre-operative preparation for 12 hours
Number of subjects: 73
Study 2669718 — intervention group
Group type: COMPARATOR
Intervention: Unprepared limbs
Number of subjects: 73
Study 2669718 — intervention group
Group type: EXPERIMENTAL
Intervention: Prepared limbs with distal ulcers or moist gangrenous lesions
Number of subjects: 73
Study 2669718 — intervention group
Group type: COMPARATOR
Intervention: Unprepared limbs with distal ulcers or moist gangrenous lesions
Number of subjects: 73
Study 2669718 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-operative antiseptic preparation
Number of subjects: 73
Study 770363 — intervention group
Group type: EXPERIMENTAL
Intervention: Pimozide at doses of 2 mg/day
Number of subjects: 50
Study 770363 — intervention group
Group type: COMPARATOR
Intervention: Diazepam at doses of 3 x 5 mg
Number of subjects: 50
Study 31668822 — intervention group
Group type: EXPERIMENTAL
Intervention: HEV-infected inpatients
Number of subjects: 1152
Study 31668822 — intervention group
Group type: EXPERIMENTAL
Intervention: HEV-infected inpatients with hepatitis B
Number of subjects: 1152
Study 31149980 — intervention group
Group type: EXPERIMENTAL
Intervention: Early Books group (received books starting at 2 weeks)
Number of subjects: 0
Study 31149980 — intervention group
Group type: COMPARATOR
Intervention: Standard group (received books starting at 6 months)
Number of subjects: 0
Study 31149980 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (shared reading counseling)
Number of subjects: 0
Study 31149980 — intervention group
Group type: COMPARATOR
Intervention: Early Books group vs Standard group
Number of subjects: 0
Study 28385672 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD therapy with shocks
Number of subjects: 1030
Study 28385672 — intervention group
Group type: COMPARATOR
Intervention: ICD therapy with ATP
Number of subjects: 1030
Study 28385672 — intervention group
Group type: EXPERIMENTAL
Intervention: Inappropriate ICD shocks
Number of subjects: 1030
Study 28385672 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall health care utilization (HCU)
Number of subjects: 1030
Study 24950280 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver transplantation
Number of subjects: 68
Study 24950280 — intervention group
Group type: COMPARATOR
Intervention: First-line chemotherapy
Number of subjects: 68
Study 24101169 — intervention group
Group type: EXPERIMENTAL
Intervention: Sentinel lymph node (SLN) surgery after neoadjuvant chemotherapy
Number of subjects: 663
Study 21097687 — intervention group
Group type: COMPARATOR
Intervention: Normal mill‐run, steam‐flaked corn plus added fat (NMR)
Number of subjects: 120
Study 21097687 — intervention group
Group type: EXPERIMENTAL
Intervention: High‐oil, steam‐flaked corn (HOC)
Number of subjects: 120
Study 19752409 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive Web‐based motivational assessment and personalized feedback (10 minutes)
Number of subjects: 2050
Study 19752409 — intervention group
Group type: COMPARATOR
Intervention: Control group (only screening)
Number of subjects: 2050
Study 17695381 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution MR angiography
Number of subjects: 37
Study 17695381 — intervention group
Group type: COMPARATOR
Intervention: Digital subtraction (DS) angiography
Number of subjects: 37
Study 15197201 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluorouracil-based combination chemotherapy
Number of subjects: 1080
Study 15197201 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretreatment quality of life measures (physical, role functioning, global QoL)
Number of subjects: 1080
Study 11473559 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine 1.5 mg kg‐1 (group L)
Number of subjects: 20
Study 11473559 — intervention group
Group type: COMPARATOR
Intervention: 0.9% saline (group S)
Number of subjects: 20
Study 9710337 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive acupuncture (25 treatment sessions over 2 months, each lasting 30 minutes)
Number of subjects: 54
Study 9710337 — intervention group
Group type: COMPARATOR
Intervention: Placebo (not specified in detail)
Number of subjects: 54
Study 7977545 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized smoking cessation counseling
Number of subjects: 600
Study 7977545 — intervention group
Group type: COMPARATOR
Intervention: Usual care (advice from obstetrician or nurse-midwife)
Number of subjects: 600
Study 28622023 — intervention group
Group type: EXPERIMENTAL
Intervention: Epilogue included
Number of subjects: 89
Study 25794439 — intervention group
Group type: EXPERIMENTAL
Intervention: Fortified yogurt (FY; 2000 IU vitamin D in 100 g/day)
Number of subjects: 59
Study 25794439 — intervention group
Group type: COMPARATOR
Intervention: Plain yogurt (PY)
Number of subjects: 59
Study 24037542 — intervention group
Group type: EXPERIMENTAL
Intervention: Second Life role-playing
Number of subjects: 0
Study 24037542 — intervention group
Group type: EXPERIMENTAL
Intervention: Phone role-playing
Number of subjects: 0
Study 24037542 — intervention group
Group type: COMPARATOR
Intervention: In-person role-playing
Number of subjects: 0
Study 24037542 — intervention group
Group type: EXPERIMENTAL
Intervention: Second Life and Phone modalities
Number of subjects: 0
Study 22016371 — intervention group
Group type: EXPERIMENTAL
Intervention: Calorie Restriction (CR)
Number of subjects: 39
Study 22016371 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise-induced weight loss (EX)
Number of subjects: 39
Study 22016371 — intervention group
Group type: COMPARATOR
Intervention: Control group (CON)
Number of subjects: 39
Study 20386332 — intervention group
Group type: COMPARATOR
Intervention: EX‐1 (exercise session on day 3)
Number of subjects: 10
Study 20386332 — intervention group
Group type: COMPARATOR
Intervention: EX‐3 (exercise sessions on days 1‐3)
Number of subjects: 10
Study 20386332 — intervention group
Group type: EXPERIMENTAL
Intervention: CON (no exercise on days 1‐3)
Number of subjects: 10
Study 17327864 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (5.9 g/day total n‐3 fatty acids; 1.8 g 20:5n‐3, 3.0 g 22:6n‐3)
Number of subjects: 26
Study 17327864 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (8.5 g/day 18:2n‐6 FA)
Number of subjects: 26
Study 16648093 — intervention group
Group type: EXPERIMENTAL
Intervention: Aromatherapy massage with 1% Santalum album (Sandalwood) (group A)
Number of subjects: 34
Study 16648093 — intervention group
Group type: COMPARATOR
Intervention: Massage with Sweet Almond Carrier oil (group B)
Number of subjects: 34
Study 16648093 — intervention group
Group type: COMPARATOR
Intervention: Sandalwood oil via an aromastone (group C)
Number of subjects: 34
Study 14653832 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous pamidronate (30 mg) in combination with oral calcium (500 mg) and vitamin D (400 IU)
Number of subjects: 74
Study 14653832 — intervention group
Group type: COMPARATOR
Intervention: Oral calcium (500 mg) and vitamin D (400 IU) alone
Number of subjects: 74
Study 10875311 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapeutic and orthotic stabilisation of hyperlax joints
Number of subjects: 0
Study 10875311 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive enhancement
Number of subjects: 0
Study 10875311 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy
Number of subjects: 0
Study 8803486 — intervention group
Group type: EXPERIMENTAL
Intervention: Summer camps for diabetic children
Number of subjects: 256
Study 8803486 — intervention group
Group type: COMPARATOR
Intervention: No participation in summer camps
Number of subjects: 256
Study 1354411 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.1% ophthalmic solution of 8-hydroxycarteolol
Number of subjects: 0
Study 1354411 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01%, 0.1%, 0.5%, and 1% ophthalmic solutions of 8-hydroxycarteolol
Number of subjects: 0
Study 6150320 — intervention group
Group type: EXPERIMENTAL
Intervention: Early moderate dietary protein restriction
Number of subjects: 228
Study 6150320 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 228
Study 30583518 — intervention group
Group type: EXPERIMENTAL
Intervention: Navy bean consumption (35 g of cooked navy bean daily)
Number of subjects: 18
Study 30583518 — intervention group
Group type: COMPARATOR
Intervention: Control group (0 g of navy beans)
Number of subjects: 18
Study 26323560 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum androgen blockage for 9 months
Number of subjects: 209
Study 26323560 — intervention group
Group type: COMPARATOR
Intervention: Bicalutamide 150 mg for 9 months
Number of subjects: 209
Study 24736197 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 ppm Cd plus 1.2% P
Number of subjects: 50
Study 24736197 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ppm Cd plus 1.2% P
Number of subjects: 50
Study 24736197 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 50
Study 24736197 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 ppm Cd
Number of subjects: 50
Study 24736197 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 ppm Cd
Number of subjects: 50
Study 22640923 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating Diet
Number of subjects: 120
Study 22640923 — intervention group
Group type: EXPERIMENTAL
Intervention: Mediterranean Diet
Number of subjects: 120
Study 22640923 — intervention group
Group type: COMPARATOR
Intervention: Control (not explicitly mentioned)
Number of subjects: 120
Study 20720255 — intervention group
Group type: EXPERIMENTAL
Intervention: Large-array meal (ad libitum access to a very large array of lunch-type foods >10,000 kcal)
Number of subjects: 78
Study 20720255 — intervention group
Group type: COMPARATOR
Intervention: Standardized meal (providing 50% of the daily estimated energy requirements)
Number of subjects: 78
Study 19099004 — intervention group
Group type: EXPERIMENTAL
Intervention: Phase 1 clinical trials with healthy volunteers
Number of subjects: 0
Study 19099004 — intervention group
Group type: COMPARATOR
Intervention: Phase 1 trials with controls
Number of subjects: 0
Study 15955757 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based intervention (n = 163)
Number of subjects: 324
Study 15955757 — intervention group
Group type: COMPARATOR
Intervention: Usual care (n = 161)
Number of subjects: 324
Study 12711406 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (n = 40)
Number of subjects: 90
Study 12711406 — intervention group
Group type: COMPARATOR
Intervention: Paroxetine (n = 50)
Number of subjects: 90
Study 10502870 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated regional taste-testing system
Number of subjects: 0
Study 8604060 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular advancement surgery
Number of subjects: 20
Study 2007100 — intervention group
Group type: EXPERIMENTAL
Intervention: Parascalene block with 0.5 ml/kg 0.25% bupivacaine with 1:200,000 epinephrine
Number of subjects: 19
Study 2007100 — intervention group
Group type: COMPARATOR
Intervention: Sham injection (subcutaneous needle puncture only)
Number of subjects: 19
Study 2007100 — intervention group
Group type: EXPERIMENTAL
Intervention: Parascalene block
Number of subjects: 19
Study 2007100 — intervention group
Group type: COMPARATOR
Intervention: Sham injection
Number of subjects: 19
Study 7034757 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 1.5 ml in 8% glucose
Number of subjects: 30
Study 7034757 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 2 ml in 8% glucose
Number of subjects: 30
Study 7034757 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine 3 ml in 8% glucose
Number of subjects: 30
Study 31649364 — intervention group
Group type: EXPERIMENTAL
Intervention: Solifenacin
Number of subjects: 47
Study 31649364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron
Number of subjects: 47
Study 31649364 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirabegron to Solifenacin switch
Number of subjects: 47
Study 31119907 — intervention group
Group type: EXPERIMENTAL
Intervention: Customized compression garment (CG) worn for 6 weeks
Number of subjects: 56
Study 31119907 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 56
Study 27322695 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction CapeOx followed by chemoradiotherapy with CapeOx (CapeOx‐RT) (arm A)
Number of subjects: 38
Study 27322695 — intervention group
Group type: COMPARATOR
Intervention: CapeOx‐RT alone (arm B)
Number of subjects: 38
Study 24081667 — intervention group
Group type: EXPERIMENTAL
Intervention: Cemented hemiarthroplasty
Number of subjects: 220
Study 24081667 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented hemiarthroplasty
Number of subjects: 220
Study 22810435 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraaortic balloon pulsation (IABP) support
Number of subjects: 40
Study 22810435 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 40
Study 22810435 — intervention group
Group type: EXPERIMENTAL
Intervention: Cytokine levels (INF‐γ, TNF‐α, MIP‐1β, G‐CSF, MCP‐1β)
Number of subjects: 40
Study 20938172 — intervention group
Group type: EXPERIMENTAL
Intervention: βS-haplotypes (CAR, Ben, etc.)
Number of subjects: 221
Study 18988231 — intervention group
Group type: EXPERIMENTAL
Intervention: Quality of Life (QOL) preference
Number of subjects: 459
Study 18988231 — intervention group
Group type: EXPERIMENTAL
Intervention: Length of Life (LOL) preference
Number of subjects: 459
Study 15745927 — intervention group
Group type: EXPERIMENTAL
Intervention: hGH treatment (0.23 mg/kg per week)
Number of subjects: 13
Study 15745927 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy subjects)
Number of subjects: 13
Study 14608063 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid plus iron (60 mg)
Number of subjects: 0
Study 14608063 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid plus iron and zinc (30 mg)
Number of subjects: 0
Study 14608063 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid plus iron, zinc and multiple micronutrients
Number of subjects: 0
Study 14608063 — intervention group
Group type: COMPARATOR
Intervention: Vitamin A alone
Number of subjects: 0
Study 14608063 — intervention group
Group type: EXPERIMENTAL
Intervention: Folic acid alone
Number of subjects: 0
Study 10864732 — intervention group
Group type: COMPARATOR
Intervention: Standard volume of local anaesthetic containing lignocaine 2% and adrenaline (1/80 000)
Number of subjects: 44
Study 10864732 — intervention group
Group type: EXPERIMENTAL
Intervention: Double the standard volume of local anaesthetic containing lignocaine 2% and adrenaline (1/80 000)
Number of subjects: 44
Study 9201091 — intervention group
Group type: COMPARATOR
Intervention: Ranitidine 150 mg intravenously daily (N = 35)
Number of subjects: 67
Study 9201091 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 40 mg daily orally or by nasogastric route (N = 32)
Number of subjects: 67
Study 8382712 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified dietary therapy (12 months of intensified education)
Number of subjects: 86
Study 8382712 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensified dietary therapy
Number of subjects: 86
Study 8382712 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (visits to local health centers)
Number of subjects: 86
Study 3097701 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (active drug)
Number of subjects: 14
Study 3097701 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 30803814 — intervention group
Group type: EXPERIMENTAL
Intervention: Breast arterial calcification (BAC) present
Number of subjects: 405
Study 30293597 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (2000 mg)
Number of subjects: 16
Study 30293597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 27528547 — intervention group
Group type: EXPERIMENTAL
Intervention: Nb‐U.V.B plus OMP
Number of subjects: 45
Study 27528547 — intervention group
Group type: EXPERIMENTAL
Intervention: Nb‐U.V.B alone
Number of subjects: 45
Study 27528547 — intervention group
Group type: COMPARATOR
Intervention: OMP alone
Number of subjects: 45
Study 24743579 — intervention group
Group type: EXPERIMENTAL
Intervention: Limb RIPC
Number of subjects: 216
Study 24743579 — intervention group
Group type: COMPARATOR
Intervention: Conventional lung resection (control)
Number of subjects: 216
Study 22777103 — intervention group
Group type: EXPERIMENTAL
Intervention: 12‐h training of reaching using the SMART Arm device
Number of subjects: 28
Study 20940250 — intervention group
Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 159
Study 20940250 — intervention group
Group type: COMPARATOR
Intervention: Antiarrhythmic drugs (AADs)
Number of subjects: 159
Study 17435519 — intervention group
Group type: EXPERIMENTAL
Intervention: Menicon Z (MZ) lens (Dk/t = 90.6)
Number of subjects: 20
Study 17435519 — intervention group
Group type: COMPARATOR
Intervention: Equalens II (EII) lens (Dk/t = 47.2)
Number of subjects: 20
Study 17435519 — intervention group
Group type: EXPERIMENTAL
Intervention: Menicon Z (MZ) lens
Number of subjects: 20
Study 17435519 — intervention group
Group type: COMPARATOR
Intervention: Equalens II (EII) lens
Number of subjects: 20
Study 16140519 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine plus fentanyl (8 mL of 0.125% solution plus fentanyl 50 microg, maintained with 0.0625% solution with fentanyl 2 microg/mL)
Number of subjects: 40
Study 16140519 — intervention group
Group type: COMPARATOR
Intervention: Epidural ropivacaine plus fentanyl (8 mL of 0.125% solution plus fentanyl 50 microg, maintained with 0.0625% solution with fentanyl 2 microg/mL)
Number of subjects: 40
Study 12383807 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined viscocanalostomy, phacoemulsification, and intraocular lens (IOL) implantation
Number of subjects: 114
Study 12383807 — intervention group
Group type: COMPARATOR
Intervention: Combined trabeculotomy, phacoemulsification, and IOL implantation
Number of subjects: 114
Study 12383807 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined viscocanalostomy, phacoemulsification, and IOL implantation
Number of subjects: 114